VTv Therapeutics Prices IPO At $15.00/shr - Quick Facts

(RTTNews) - vTv Therapeutics Inc. (VTVT) announced that it has priced its initial public offering of 7.81 million shares of its Class A common stock at a price to the public of $15.00 per share. All of the shares are being offered by the Company.

In addition, the Company has granted the underwriters an option to purchase up to an additional 1.17 million shares of Class A common stock. The shares of Class A common stock are expected to begin trading on the Nasdaq Global Market on July 30, 2015, under the symbol "VTVT."

The company noted that it plans to use the net proceeds of the offering to fund the STEADFAST Study (its ongoing Phase 3 trial of azeliragon, a drug candidate for the treatment of Alzheimer's disease), further clinical development of its other drug candidates (including two drug candidates for the treatment of type 2 diabetes that are in or commencing Phase 2 studies) and for working capital and other general corporate purposes.